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SUMMARY 
Post-ischemic inflammatory changes in the central nervous system (CNS) 
following cardiac arrest and resuscitation are potentially responsible for 
ultimate survival and much of the neurologic damage, producing greater 
morbidity and mortality in successfully resuscitated patients. This study was 
undertaken to assess the non-steroidal anti-inflammatory agent, ibuprofen, 
in a controlled and monitored experimental model of canine cardiac arrest 
and resuscitation. With the investigator blinded as to the intervention, eight 
of 21 dogs were randomly assigned to receive ibuprofen as an i.v. bolus 
(10 mg/kg) and a 6-h i.v. infusion (5 mg/kg per h). The other 13 dogs 
received an equivalent volume of 0.9% NaCl to serve as controls. No statisti- 
cally significant differences between the two groups were detected in any 
pre-arrest variables. All 21 dogs were successfully resuscitated. At 24 h, dogs 
receiving ibuprofen exhibited 100% survival, while control dogs exhibited 
only 54% survival (P = 0.03). The majority of deaths for the control group 
occurred within the first 6 h. Neurologic deficit scores were assigned at 1, 2, 
6 and 24 h after resuscitation. A general trend occurred such that dogs 
treated with ibuprofen improved over time, while the control dogs remained 
severely impaired. A significant difference in neurologic deficit score was 
detected at 6 h (P = 0.01). At 24 h the ibuprofen group exhibited minimal 
neurologic deficit (5.9 + 3.2), and the control group exhibited significantly 
more severe neurologic impairment (52.2 f 13.0, P = 0.01). These results 
suggest that ibuprofen may be helpful in the pharmacologic management of 
cardiac arrest as a means of increasing survival and decreasing neurologic 
impairment. 
*This study wa8 made possible by gift from the Upjohn Company, Kalamazoo, MI 49001, 
U.S.A. 
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INTRODUCTION 
Despite standardization of techniques and pharmacologic protocols for 
resuscitation, cardiac arrest remains a leading cause of morbidity and mor- 
tality in industrialized nations. Most series report survivals of less than 20% 
and neurologic morbidity in survivors is profound. In a recent lo-year retro- 
spective study from Seattle (Longstreth et al., 1983a and b), the most 
successful experience reported to date, an unprecedented 50% of all cardiac 
arrest patients were successfully resuscitated, and yet only 41% of those 
resuscitated regained consciousness without neurologic impairment. In this 
favorable series a completely successful result following resuscitation from 
cardiac arrest thus only occurred 20% of the time. 
In attempts to improve this outcome, a number of therapeutic interven- 
tions have been tested experimentally in both the laboratory and the clinical 
setting. These include pharmacologic agents such as barbiturates, steroidal 
and non-steroidal anti-inflammatory drugs, calcium channel blockers, oxygen 
radical scavengers, various diuretics and osmotics, and a plethora of agents 
with hemodynamic effects. Ibuprofen, a non-steroidal anti-inflammatory 
agent has not yet been tested in the setting of cardiac arrest and resuscita- 
tion. However, ibuprofen has been shown to reduce myocardial infarct size 
in dogs by up to 49% (Jugdutt et al., 1980), presumably due to an inhibition 
of inflammatory mediators (Flynn et al., 1984). Because the neural damage 
following circulatory arrest may be caused at least in part by similar inflam- 
matory mechanisms, we decided to investigate the role that ibuprofen may 
play in improving the neurologic outcome and survival in the setting of 
cardiac arrest and resuscitation. 
METHODS 
Preparation and experimental procedure 
Twenty-one fed mongrel dogs (15.9-28.6 kg) were pre-medicated with 
morphine sulfate, (1.5 mg/kg i.m.). Anesthesia was induced with 5% halo- 
thane via mask and demand ventilation. Once anesthetized, the dogs were 
intubated and maintained on l-2% halothane (Compact-75, Foregger, 
Westmont, IL) via controlled ventilation (Anesthesia Ventilator, Bennettt, 
Westmont, IL). Neuromuscular blocking agents were not used. Carbon 
dioxide concentration in respiratory gas was continuously monitored with 
an infrared analyzer (LB-2, Beckman, SensorMedics Co, Anaheim, CA) and 
end expiratory COZ was maintained between 4-5s. An esophageal tempera- 
ture probe was inserted to the level of the heart. Body temperature was 
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monitored and maintained at 39°C with a heating pad and proportional 
controller. An indwelling urethral catheter was placed to allow estimation 
of urine production. Two venous catheters were inserted. One catheter was 
inserted through the femoral vein for fluid infusion. A second catheter, 
which was used for resuscitation drug administration and central venous 
pressure monitoring, was advanced through the external jugular vein to the 
superior vena cava so that the tip lay near the right atrial opening. A catheter 
was advanced from the femoral artery to the common iliac artery to monitor 
pulsatile blood pressure. 
A left thoracotomy in the fifth intercostal space provided access to the 
heart, and the pericardium was opened to facilitate direct cardiac compres- 
sion. Subcutaneous electrocardiographic electrodes were placed to monitor 
Lead II ECG. This ECG, along with mean and pulsatile arterial pressure, 
heart rate, and expiratory carbon dioxide tension were recorded on an oscil- 
lograph (Gould-Brush 200, Cleveland, OH). When the preparation was com- 
plete, the dogs were disconnected from the anesthesia machine and con- 
nected to a room air ventilator (Harvard 607, South Natick, MA) to reduce 
and standardize the level of anesthesia at which fibrillation would be induced. 
The heart was fibrillated after cornea1 reflexes had consistently returned by 
delivering a 60 Hz, 2ms square wave stimulus to the epicardial surface of the 
left ventrical. Circulatory arrest was confirmed by evaluation of the ECG 
tracing, arterial pressure pulse, and by direct observation. 
After 6 min of circulatory arrest resuscitation began with direct cardiac 
massage, which maintained arterial blood pressure above 75 mmHg. In all 
dogs drugs were rapidly injected into the central venous catheter in the 
following sequence and doses: an epinephrine injection (20 pg/kg) and 
infusion (4 pg/kg per min via femoral venous catheter), an injection of 
NaHCO, (2 meq/kg), an injection of lidocaine (1 mg/kg), and an injection of 
CaClz (25 mg/kg). At this point a bolus injection of either ibuprofen (10 mg/ 
kg) or an equivalent volume of 0.9% NaCl was administered. Dogs receiving 
an ibuprofen bolus (N = 8) also received an infusion of ibuprofen (5 mg/kg 
per h) for 6 h, and dogs receiving a bolus of saline (N = 13) received an equi- 
valent volume of 0.9% NaCl infused at the same rate (approx. 9.0 ml/h). The 
dogs were biock randomized in groups of three and four (treatment and 
control respectively) which should have given sample sizes of 9 and 12, how- 
ever, one animal was misassigned resulting in the final sample size of 8 
treated and 13 control animals. The investigators were blinded to the treat- 
ment throughout the study. All dogs received 5% dextrose in lactated 
Ringer’s solution at 120 ml/h for the first 6 h and at 65 ml/h for the next 
18 h (total volume less than 2 1 in 24 h). 
As soon as the initial sequence of drugs was administered (approx. 1 min) 
defibrillation was attempted by delivering a charge of 40-805, (Physio- 
Control, Lifepak-3, Worthington, OH), with 31 sq cm paddles placed on the 
ventricular surface. Additional injections or charges were administered when 
indicated by arterial blood pressure and ECG tracings. Epinephrine infusion 
202 
was adjusted to maintain mean arterial pressure between 100 and 125 mmHg, 
and was stopped when the dog was capable of maintaining a mean pressure 
greater than 100 mmHg, or at 6 h post-arrest. 
The chest was closed and evacuated when a stable rhythm and pressure 
developed. The dogs were ventilated until spontaneous ventilation returned, 
and were extubated upon the return of the gag reflex. The dogs were then 
placed in a cage where blood pressure, heart rate, ECG and central venous 
pressure were continuously monitored for 24 h using a standard dog jacket 
and swivel (Alice King Chatham Medical Arts, Los Angeles, CA). An anti- 
biotic (Polyflex, 6.6 mg/Kg i.m.) was given to all dogs, and morphine sulfate 
(1.5 mg/Kg i.m.) was used as needed when the dogs showed signs of pain or 
discomfort. 
At 1, 2, 6 and 24 h post-arrest, a neurologic score (D’Alecy, 1986) des- 
cribed in Table I was assigned. All scoring was done by two or more blinded 
investigators, who referred to written descriptions of each test condition. 
Postmortem examinations of the heart, lungs and wound site were con- 
ducted to identify hemorrhage, heartworm infestation, catheter placements 
or any iatrogenic problem relating to the thoracotomy or resuscitation that 
may have. contributed to the death of any of the dogs. The entire experi- 
mental procedure conformed to the guidelines set by the American Physio- 
logical Society and was approved by The University of Michigan Unit for 
Laboratory Animal Medicine’s Vertebrate Animal Use Committee 
(D001068D). 
Data analysis 
Statistical analysis was performed with the aid of the Michigan Interactive 
Data Analysis System (MIDAS) on an Amdahl 5860 computer. Both the 
parametric Student’s t-test and non-parametric Kruskel-Wallis tests were used 
to evaluate neurologic scores. Fisher’s exact test was used for survival data. 
All average data are expressed as mean + one standard error of the mean 
(S.E.M.). The sample size (N) for all experiments is the number of animals. 
Exact P-values are given except when P > 0.15 where it is reported as non- 
significant (NS). 
RESULTS 
For the two groups, the average values of the pre-arrest variables of body 
weight, operative time (anesthesia induction to fibrillation), mean arterial 
pressure, heart rate, and end-expiratory carbon dioxide were not statistically 
different (Table II). 
All 21 dogs were successfully resuscitated. Figure 1 illulstrates the time of 
death for each dog and the survival for each group to 24 h. All dogs receiving 
ibuprofen survived (N = 8), while the group that did not receive ibuprofen 
(the control group, N = 13) showed significant mortality in the first 6 h. 
At 24 h, the control group exhibited only 54% survival which is significantly 
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TABLE I 
NEUROLOGIC DEFICIT SCORE 
Neurologic deficit score was previously published (D’Alecy, 1986) and addresses five 
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On ventilator (16) 
Subtotal 118 
Cruniul nerves 
(Strong = 0, Weak = 1, Absent = 2) 
Cornea1 reflex (2) 
Pupillary light reflex (2) 
Facial sensation (2) 
Gag reflex (2) 
Jaw reflex (2) 
Olfactory reflex (2) 
Swallowing reflex (2) 
Subtotal / 16 
Spinal nerves 
(Normal = 0, Spastic = 2, Faccid = 4) 
Limb tone: front (4) 
Limb tone: hind (4) 
(Normal = 0, Weak = 2, Absent = 4) 
Pain reflex : front (4) 
Pain reflex: hind (4) 
Knee jerk reflex (4) 
Subtotal I20 
TOTAL = /lOO 
lower than the ibuprofen group’s 100% survival (Fisher’s exact, P = 0.03). 
No differences between groups were detected for the resuscitation time 
(the time from the beginning of resuscitation to the establishment of stable 
cardiac rhythm and a mean arterial blood pressure greater than 75 mmHg 
without external compression), the number of defibrillating shocks, the time 
the animals had to be ventilated, the time until the animals were extubated, 
amount of epinephrine administered (as both the injection and infusion), the 
NaHCOJ, lidocaine, calcium chloride, or morphine used (Table III). 
Figure 2 depicts the mean arterial pressure during pre-arrest period and 




Average pre-arrest variables for the ibuprofen-treated and the vehicle control group of 
dogs given as the mean t one standard error of the mean. P-values reflect Student’s t-tests 
for all variables. 
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138 f 17 135 + 6 NS 
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Fig. 1. Percent survival for the ibuprofen-treated group and the vehicle control group 
plotted against time in hours. The sample size for the ibuprofen treated group was eight, 
and the initial sample size for the vehicle control group was 13. ??-0, ibuprofen in- 
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Fig. 2. The symbols at the far left indicate one standard error of the mean about the 
pre-arrest values of mean arterial pressure for the two groups. The box with arrows 
indicates the range in which pressure was controlled for the 6 h following arrest and 
resuscitation. Sample size is next to each data point. Values were taken just after 6 h 
when pressure stabilized and at 7, 12, 18 and 24 h post-resuscitation. At no time were 
the two groups significantly different, ??, 6-h ibuprofen infusion; A, vehicle control. 
differences between groups in blood pressure for any time throughout the 
experiment. Furthermore, heart rates measured at 6 and 24 h, and end- 
expired CO,, both on the ventilator and when the animals were taken off the 
ventilator were not significantly different (Table IV). 
Statistical analysis of the neurologic deficit score (Table I) of the groups 
at one, two, six, and 24 hours is illustrated in Fig. 3. If a dead animal is 
scored as 100 both parametric (Student’s t, top row) and non-parametric 
(Kruskal-Wallis, bottom row) analysis of the deficit is possible. The inclusion 
of a dead dog in a neurologic deficit score may be misleading, especially if 
the cause of death could be attributed to non-neurologic causes. We included 
such subjects in our neurologic scoring for the following reasons: (1) post- 
mortem examination did not reveal any iatrogenic problems related to the 
thoracotomy or resuscitation that could account for the death of any 
animal; (2) none of the dogs died from ventricular fibrillation and most dogs 
(N = 19) had regained spontaneous ventilation with hyperpnea within less 
than 1 h (all dogs within 3 h); (3) cardiopulmonary depression appeared to 
be secondary to progressive neurologic damage as evidenced by stable ECG 
rhythms; and (4) all the animals that died had fixed and dilated pupils, little 
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TABLE III 
RESUSCITATION PROCEDURE VARIABLES 
Average values of the resuscitation procedure variables for the ibuprofen-treated and the 
vehicle control groups of dogs. Values are presented as the mean f one standard error of 
the mean. The P-values are from Student’s f-test in all cases. 
Variable name 6 h ibuprofen Vehicle P 
infusion control 
Sample size (N) 
Resuscitation time 
(min) 





Epi injection dose 
(mg/kg) 
Epi infusion time 
(min) 
Total NaHCO, dose 
(meq/kg) 







7.5 + 1.8 
3 +1 
23 f 2 
161 +58 157 +34h 
51.5 f 2.6 66.2 f 4.1 
33 + 4 
2.3 + 0.3 
6.1 + 1 
31 + 6 
2.1 f 0.7 
13 
10.4 + 2.9 
4 +1 
51 + 17a 
83 f 31 
2.6 + 0.4 
6.2 + 1 
44 -+ 1 











aeb These values were obtained with a smaller sample size than indicated due to death and 
othercauses:a=(N-l),b=(N-2). 
or no somatosensory response, and death was often preceded by convulsive- 
like activity, and limb extension with arching of the back. 
For neurologic deficit, a general trend developed such that the neurologic 
deficit decreases over time for the ibubrofen-treated animals, while the 
control group remains significantly impaired (Fig. 3). Statistically significant 
differences (P < 0.05) between the two groups developed as early as 6 h 
after the resuscitation. The ibuprofen-treated animals displayed moderate 
neurologic impairment (30.1+ 2.0), while the control animals displayed 
significantly (Student’s t, P = 0.016) more severe impairment (58.7 f 8.2). 
At 24 h, the dogs receiving ibuprofen displayed a mean neurologic deficit 
score of 5.9 + 3.2, while the vehicle control group had more severe neurologic 
deficit, displaying a score of 52.2 + 13.0 (Student’s t, P = 0.013). Even if the 
dead control dogs are not included in the neurologic scoring, the dogs 
receiving ibuprofen averaged about half the neurologic deficit of the surviv- 
ing control dogs (5.9 + 3.2 as compared to 11.3 + 5.2) however, this diffe- 
rence was not statistically significant (P = 0.38). 
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TABLE IV 
POST-RESUSCITATION PHYSIOLOGIC MEASUREMENTS 
Average values for the post-resuscitation variables for the ibuprofen-treated and the 
vehicle control group of dogs. All values are presented as the mean + one standard error 
of the mean. The P-values are from Student’s t-test. Sample size is given for each measure- 
ment. Missing values are due to death or mechanical failure. 
Variable name N 6 h ibuprofen N Vehicle P 
infusion control 
Heart rate 6 h 
(beatslmin) 8 127 A17 8 167 215 NS 
Heart rate 24 h 
(beats/min) 7 144 + 13 7 125 +13 NS 
End expired CO, on 
ventilator (%) 8 4.5 f 0.2 12 4.3 + 0.2 NS 
End expired CO, off 
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Fig. 3. Post-resuscitation Neurologic Deficit. Values are the mean 2 one standard error of 
the mean for the total neurologic score. St’ indicates P-values for Student’6 t-parametric 










In our hands, controlled cardiac arrest and resuscitation has been highly 
successful. Of 64 animals used for this and previous studies, 63 were success- 
fully resuscitated; a failure rate of less than 1.6% (D’Alecy et al., 1986; 
Lundy et al., 1986). The drugs selected for use in this model were chosen to 
simulate a restricted and simplified advanced cardiac life support protocol. 
These restrictions were required to permit testing in a controlled experi- 
mental setting rather than optimizing resuscitation outcome by utilizing the 
full spectrum of interventions reported as effective in resuscitation. 
Although calcium chloride is no longer a part of the ACLS protocol, it was 
included in our treatment regimen because preliminary studies indicated it 
was needed to reduce electromechanical dissociation observed following 
prolonged arrests. The sodium bicarbonate dose was choosen to produce an 
arterial blood pH around 7.41. All dogs were fed prior to testing and all 
were given the same amount of dextrose to control for the potential damag- 
ing effects on resuscitation outcome of an elevated blood glucose (Myers and 
Yamaguchi, 1976; Longsteth et al., 1983b; D’Alecy et al., 1986; Lundy et 
al., 1986). The neurologic scoring used is our modification of schemes 
developed by Safar et al. (1976) and used by Todd et al. (1981 and 1982). 
To reduce bias, the scoring was done by individuals unaware of the treat- 
ment status of the animal, To increase consistency in the scoring, two or more 
investigators consulted written descriptions of each condition before a single 
score was agreed upon. 
A potential criticism of this scoring method involved the inclusion of dead 
animals in a neurologic impairment scale. We feel justified in including the 
dead dogs in a neurologic impairment scale because their deaths were not 
due to ventricular fibrillation, hemorrhage or pneumothorax. The pattern of 
death was clearly suggestive of a primary cerebral event with maximum deficit 
in cranial and spinal nerves recorded prior to progressive depression of 
cardiopulmonary function. While it is true that the removal of these dead 
animals from the analysis eliminates the statistical separation of the groups 
it, at the same time, biases the data strongly in favor of the untreated group. 
All of the most severely damaged animals would be removed from the un- 
treated group leaving only the least impaired animals of this group to com- 
pare with all the animals in the treatment group. 
Therapeutic potential of ibuprofen 
In addition to the clinical uses of ibuprofen as a potent anti-inflammatory 
agent, experiments have suggested that ibuprofen may have clinical applica- 
tions in reducing myocardial infarct size (Jugdutt et al., 1980; Romson et al., 
1982; Kirlin et al., 1982), improving the outcome following endotoxic shock 
(Jacobs et al., 1982), and improving survival in acute respiratory failure due 
to sepsis (Kopolovic et al., 1984). In this study we have shown that ibupro- 
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fen may have an application in improving survival and neurologic recovery of 
resuscitated victims of cardiac arrest. Although ibuprofen may improve 
survival in the short term (12-24 h), it may not effect long term (weeks to 
months) neurologic impairment of survivors. The infusion of ibuprofen was 
only for 6 h and extending the time of infusion may be required to deter- 
mine if long range effects are present. 
Because the actions of ibuprofen are many and not yet fully explored, the 
proposed mechanisms of cerebral protection remain speculative. Ibuprofen 
is reported to limit granulocyte aggregation (McManus et al., 1980; Romson 
et al., 1982; Flynn et al., 1984). Normally, granulocytes aggregate in the 
presence of certain chemotactic agents such as C5a of the complement 
system (Jacob et al., 1980; Hammerschmidt et al., 1981). These chemo- 
taxins are activated with the concurrent activation of the coagulation 
cascade, which follows cerebral ischemia (Anderson et al., 1974). These 
aggregations of granulocytes form leukoemboli, which can potentially 
occlude small (60 pm) vessels (Hammerschmidt et al., 1981). It is known 
that with reperfusion following global ischemia, secondary changes occur 
in brain tissue that evolve into miliary microscopic infarcts (Safar, 1981). By 
preventing the granulocytes from aggregating, ibuprofen may limit leuko- 
emboli formation and thus prevent miliary infarction of neural tissue. 
Aggregated granulocytes could produce tissue damage through other 
mechanisms including: (1) the production of vasospasm-inducing leuko- 
trienes which potentially restrict blood flow to the infarcted area (Michelassi 
et al., 1982); (2) the release of lysosomal enzymes which may cause 
additional cell damage by digesting critical cell membrane components 
(Flynn et al., 1984); and (3) the production of toxic oxygen free-radicals 
which may not only damage the membranes of neurons and glial cells 
surrounding an infarct (Demopolous et al., 1980; Del Maestro et al., 1980), 
but may also damage endothelial cells (Sacks et al., 1978) setting the stage 
for edema. Indeed, Wedmore and Williams (1981) have shown that granulo- 
cytes are required to produce edema at sites of inflammation. Although the 
early edema in the reperfused CNS is commonly thought to be due to the 
cytotoxic effects of ischemia (Klatzo, 1967; Hossmann, 1976), an inflam- 
matory component which disrupts the vascular integrity may be a cause of 
vasogenic edema, which can occur late in the course in cerebral infarcts 
(Katzman, 1978). 
Ibuprofen could limit the damaging effect of cardiac arrest and resuscita- 
tion by preventing granulocytes from aggregating, however, ibuprofen has 
also been shown to markedly reduce chronic cerebral vasospasm in dogs 
(Chyatte et al., 1983). This phenomenon is most likely a result of the ability 
of ibuprofen to inhibit the formation of vasoactive leukotrienes (Vanderhoek 
and Bailey, 1984). Interestingly, in animal models of cardiac arrest and 
resuscitation, Ames et al. (1968) and others (Gadzinski et al., 1982; White 
et al., 1983a, 1983b) have demonstrated a reduction in cerebral blood flow 
with reperfusion, sometimes to as low as 20% of normal. This “No-Reflow” 
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phenomenon may be due in part to inflammatory mediators exhibiting a 
vascoactive effect. It is conceivable that by preventing the formation of these 
vasoactive compounds, ibuprofen may prevent this “No-Reflow” phenome- 
non and maintain cerebral blood flow thereby salvaging otherwise ischemic 
neural tissue. 
Ibuprofen has been reported to decrease the release of lysozomal enzymes, 
inhibit the production of superoxide radicals, and prevent granulocyte 
mediated endothelial cytotoxicity (Flynn et al., 1984). All of these mecha- 
nisms have been invoked to describe the pathology of CNS ischemic dis- 
orders (Demopoulous et al., 1980; Del Maestro et al., 1980). Supporting the 
idea that these inflammatory mediators cause neural damage in the setting 
of cardiac arrest is the observation that early, irreversible histological 
damage will only become apparent if the neural tissue is allowed to be 
reperfused (Safar, 1982). In resuscitation from cardiac arrest, reperfusion 
could conceivably introduce the granulocytes and their inflammatory media- 
tors into tissue already damaged by the transient ischemia of circulatory 
arrest. As the inflammatory mediators attempt to resolve damaged neuro- 
logic tissue, they would also cause additional damage to adjacent, healthy 
tissue. Because ibuprofen can prevent or inhibit these secondary inflamma- 
tory mechanisms, it is not unreasonable that in the setting of reperfusion 
following cardiac arrest, ibuprofen should have protective effects. 
The descriptive nature of this study leaves open the question of how 
ibuprofen increases survival and decreases neurologic morbidity. Because 
there are limited pharmacologic resources available for intervening to lessen 
the brain damage associated with cardiac arrests, the preliminary data pre- 
sented here are clearly encouraging and suggest that ibuprofen deserves 
further attention in this setting. 
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